X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
surgery (139) 139
humans (131) 131
female (114) 114
index medicus (110) 110
breast cancer (104) 104
middle aged (84) 84
oncology (76) 76
adult (72) 72
cancer (61) 61
breast neoplasms - pathology (59) 59
breast neoplasms - surgery (57) 57
aged (56) 56
retrospective studies (53) 53
article (49) 49
neoplasm staging (47) 47
care and treatment (39) 39
mastectomy (37) 37
medicine & public health (37) 37
prognosis (36) 36
women (35) 35
surgical oncology (34) 34
aged, 80 and over (29) 29
carcinoma (29) 29
health aspects (29) 29
analysis (28) 28
follow-up studies (27) 27
biopsy (26) 26
chemotherapy (25) 25
abridged index medicus (23) 23
patients (22) 22
survival (22) 22
prospective studies (21) 21
animals (20) 20
research (20) 20
breast neoplasms - diagnosis (19) 19
lumpectomy (19) 19
male (19) 19
risk factors (19) 19
sentinel lymph node biopsy (19) 19
treatment outcome (19) 19
breast neoplasms - mortality (18) 18
cancer patients (18) 18
tumors (18) 18
survival rate (17) 17
diagnosis (16) 16
medical colleges (16) 16
breast neoplasms - drug therapy (15) 15
carcinoma, ductal, breast - surgery (15) 15
mammography (15) 15
therapy (15) 15
breast neoplasms - therapy (14) 14
carcinoma, ductal, breast - pathology (13) 13
lymphatic metastasis (13) 13
mice (13) 13
mortality (13) 13
neoadjuvant therapy (13) 13
outcomes (13) 13
risk (13) 13
breast (12) 12
cancer therapies (12) 12
dissection (12) 12
follow-up (12) 12
incidence (12) 12
lymph nodes - pathology (12) 12
mastectomy, segmental (12) 12
radiotherapy (12) 12
young adult (12) 12
adjuvant treatment (11) 11
adolescent (11) 11
axilla (11) 11
breast neoplasms - epidemiology (11) 11
breast neoplasms - radiotherapy (11) 11
conserving surgery (11) 11
estrogen (11) 11
irradiation (11) 11
metastases (11) 11
metastasis (11) 11
neoplasm invasiveness (11) 11
trial (11) 11
radiation (10) 10
radiation therapy (10) 10
randomized-trial (10) 10
recurrence (10) 10
time factors (10) 10
age (9) 9
combined modality therapy (9) 9
induction (9) 9
lymphatic system (9) 9
mice, inbred c57bl (9) 9
neoadjuvant chemotherapy (9) 9
oncology, experimental (9) 9
patient outcomes (9) 9
radiology, nuclear medicine & medical imaging (9) 9
20-year follow-up (8) 8
breast neoplasms - diagnostic imaging (8) 8
breast neoplasms - genetics (8) 8
carcinoma, ductal, breast - mortality (8) 8
carcinoma, lobular - pathology (8) 8
carcinoma, lobular - surgery (8) 8
decision making (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Surgical Oncology, ISSN 1068-9265, 5/2019, Volume 26, Issue 5, pp. 1167 - 1169
Journal Article
Nature, ISSN 0028-0836, 06/2012, Volume 486, Issue 7403, pp. 353 - 360
Journal Article
ANNALS OF SURGICAL ONCOLOGY, ISSN 1068-9265, 03/2017, Volume 24, Issue 3, pp. 618 - 620
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 3/2017, Volume 24, Issue 3, pp. 618 - 620
Journal Article
JAMA Surgery, ISSN 2168-6254, 12/2014, Volume 149, Issue 12, pp. 1305 - 1305
Journal Article
Social Science & Medicine, ISSN 0277-9536, 02/2019, Volume 223, pp. 117 - 120
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4055 - 4065
Purpose: Cyclin-dependent kinase (CDK) 4/6 drives cell proliferation in estrogen receptor-positive (ER+) breast cancer. This single-arm phase II neoadjuvant... 
TRIAL | AROMATASE INHIBITOR | 1ST-LINE TREATMENT | RETINOBLASTOMA PROTEIN | ONCOLOGY | INTRINSIC SUBTYPE | IN-VIVO | DOUBLE-BLIND | LETROZOLE | CELL-PROLIFERATION | POSTMENOPAUSAL WOMEN | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Breast Neoplasms - surgery | Triazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Class I Phosphatidylinositol 3-Kinases - genetics | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Nitriles - administration & dosage | Pyridines - adverse effects | Adult | Female | Neoadjuvant Therapy | Gene Expression Regulation, Neoplastic - drug effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyridines - administration & dosage | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Disease-Free Survival | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Breast Neoplasms - pathology | Aged | Cell Proliferation - drug effects | Mutation | Neoplasm Staging | Cell proliferation | Anastrozole | Estrogens | Cyclin-dependent kinases | Estrogen | Estrogen receptors | Breast cancer | Kinases | Gene expression | Patients | ErbB-2 protein | Cyclin-dependent kinase 4 | Cyclin-dependent kinase | E2F protein | Inhibitors | Experimental design | Surgery | Cell cycle | Breast | Cancer | breast cancer | neoadjuvant | anastrozole | CDK4 | palbociclib
Journal Article